SMS Reminders to Improve the on Time Vaccination Rates Among Children in Pakistan
NCT01859546 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300
Last updated 2013-05-22
Summary
Vaccines are one of the best public health tools available to achieve the Millennium Development Goal (MDG) # 4 of decreasing child mortality. A major reason for poor childhood vaccine coverage is the lack of awareness among parents regarding the need for immunization in children, and the importance of completing the entire series of vaccines. This result in significant drop-out between vaccines delivered at birth and later in the infancy period. New innovative methods involving technologies are needed to be employed to increase the vaccine coverage. This study is being conducted in Karachi, Pakistan and main study objective is
• To assess the effectiveness of SMS reminders on cell phones in improving the compliance of subsequent visits for routine immunization for children.
Conditions
- Vaccination Failure
Interventions
- BEHAVIORAL
-
Short message service
Short message service reminders on cell phones in improving the compliance of subsequent visits for routine immunization for children
Sponsors & Collaborators
- collaborator OTHER
-
Aga Khan University
lead OTHER
Principal Investigators
-
Ibrahim M Abdel Rahim, MBBS · World Health Organization
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Week
- Max Age
- 18 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-12-31
Countries
- Pakistan
Study Locations
More Related Trials
-
Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda
NCT04177485 ·Status: COMPLETED ·Phase: NA
-
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Vaccinations (D0271)
NCT03252288 ·Status: COMPLETED ·Phase: NA
-
Non-Specific Effects of Standard Titre Measles Vaccination
NCT00168662 ·Status: COMPLETED ·Phase: PHASE4
-
Healthy, Immunized Communities Study
NCT03854734 ·Status: COMPLETED ·Phase: NA
-
Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
NCT02559960 ·Status: SUSPENDED
-
VISTA: Vaccinator-Initiated Screening and TAilored Counseling for Reducing Vaccine Hesitancy
NCT04421586 ·Status: COMPLETED ·Phase: NA
-
The Effect of ShotBlocker on Pain and Satisfaction During Measles-Rubella-Mumps Vaccination
NCT06762938 ·Status: COMPLETED ·Phase: NA
-
Immunology of Non-specific Effects of Vaccine
NCT00168545 ·Status: COMPLETED ·Phase: PHASE4
-
BCG Revaccination in Children and Adolescents
NCT05330884 ·Status: SUSPENDED ·Phase: PHASE3
-
Testing the Use of Prompts to Increase Adolescent Immunization Rates
NCT01984125 ·Status: COMPLETED ·Phase: NA
-
Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children
NCT05758532 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents
NCT00950612 ·Status: COMPLETED ·Phase: PHASE2
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Missed Opportunities for Vaccine Equity
NCT04834960 ·Status: COMPLETED ·Phase: NA
-
Increasing Vaccine Uptake Among Adolescents in the Rural South
NCT04999267 ·Status: COMPLETED ·Phase: NA
-
A Tool Kit to Improve Vaccine Confidence in the Philippines
NCT06218368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
NCT02378207 ·Status: COMPLETED ·Phase: PHASE1
-
ARISe at UMass Chan
NCT07236034 ·Status: RECRUITING ·Phase: NA
-
mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau
NCT02662595 ·Status: UNKNOWN ·Phase: NA
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Participant Centered Active Surveillance for Adverse Event Following Measles Immunization in Gedeo Zone, Ethiopia, 2022. A Multi-center Open-label Randomized Control Trial
NCT05803538 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
NCT00427830 ·Status: COMPLETED ·Phase: PHASE1
-
Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria
NCT07154836 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts
NCT00514891 ·Status: TERMINATED ·Phase: PHASE4
-
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NCT06470919 ·Status: COMPLETED ·Phase: NA